Thomas Vranken is a biotech strategist specializing in corporate development and portfolio growth. They currently serve as the Associate Director of Corporate Strategy at argenx and have held significant positions in equity research and strategy consulting at various firms, including KBC Securities and Roland Berger. Thomas has a strong academic background, having earned multiple degrees in Bioscience Engineering and Biopharmaceutical Management from esteemed institutions, consistently achieving high honors. Their extensive experience encompasses sell-side equity research, investor support, and early-stage investment assessment within the life sciences sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices